130 results
Page 3 of 7
6-K
EX-99.1
wfiiq14db4o9z
12 Nov 21
Preclinical data support armoring NKG2D CAR T cells with IL-18 to drive improved anti-tumor activity of the product candidate
7:00am
6-K
EX-99.2
k0cesfcgnh
10 Nov 21
Celyad Oncology Announces Third Quarter 2021 Financial Results and Recent Business Highlights
3:39pm
6-K
EX-99.2
m8vfbkeahg4kkn9m
4 Aug 21
Celyad Oncology Reports First Half 2021 Financial Results and Recent Business Highlights
4:01pm
6-K
EX-99.1
pxq4or8
4 Aug 21
Celyad Oncology Reports First Half 2021 Financial Results and Recent Business Highlights
4:01pm
6-K
EX-99.1
npt4 eknevx
21 Jul 21
Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day
6:03am
6-K
EX-99.2
ztbw 3kba32b6
21 Jul 21
Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day
6:03am
6-K
EX-99.2
7kbnu5zy
11 Jun 21
Current report (foreign)
7:59am
6-K
EX-99.2
jzvy80bsijhm90
7 May 21
Celyad Oncology Announces First Quarter 2021 Financial Results and Recent Business Highlights
4:17pm
6-K
EX-10.1
0956tytm
7 Jan 21
Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital
7:29am
424B5
kcgy9r45dnow1upho7
7 Jan 21
Prospectus supplement for primary offering
7:28am